HealthcareServices

Genome Editing/Genome Engineering Market Forecast: How Big Will It Be by 2030?

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genome editing/genome engineering market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Genome Editing/Genome Engineering Market expected to reach by 2030?

The genome editing/genome engineering market has witnessed rapid growth in recent years. It is projected to expand from $10.17 billion in 2025 to $12.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.5%. This historic period of growth can be attributed to key factors including the discovery of genome editing techniques, their initial applications in research, the availability of molecular biology tools, increased academic research funding, and the rising demand for disease modeling.

The genome editing/genome engineering market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $24.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.2%. Factors contributing to this growth during the forecast period include the clinical application of gene editing treatments, the broadening scope of agricultural genomics, advancements in editing precision, the establishment of ethical guidelines, and the increased availability of commercial genome editing services. Key trends anticipated in the same period involve a greater embrace of CRISPR-based editing technologies, the wider utilization of genome editing in disease investigations, an uptick in cell line engineering uses, a rising need for precise gene alterations, and enhanced financial support from academic and governmental bodies for research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What Drivers Are Driving Adoption Within The Genome Editing/Genome Engineering Market?

The anticipated growth of the genome editing and genome engineering market is expected to be propelled by an escalation in research activities. These activities encompass systematic and organized endeavors undertaken by individuals, teams, or institutions to collect, analyze, interpret, and generate new knowledge or insights within a specific field of study. Genome editing and genome engineering have evolved into critical accelerators in the increasing trend of research, thereby reshaping the panorama of scientific exploration. These innovative tools empower researchers to meticulously modify and grasp the complex genetic structure of organisms, offering unparalleled precision and adaptability. For instance, in July 2023, the National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH granted over $140 million to facilitate the acceleration of genome editing approaches from laboratory research to clinical implementation. Therefore, the rise in research activities is a primary driver for the genome editing and genome engineering market.

What Segments Are Included Within The Genome Editing/Genome Engineering Market?

The genome editing/genome engineering market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Software And Systems, Services

2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies

3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications

4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Subsegments:

1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents

2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems

3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

Which Market Trends Are Opening Growth Opportunities In The Genome Editing/Genome Engineering Market?

Leading firms form alliances and enter into collaborations to enhance their standing within the genome editing and genome engineering market. A strategic business partnership denotes a formalized relationship between multiple commercial entities, usually formalized through specific business agreements or contractual arrangements. For example, in April 2024, Regeneron Pharmaceuticals, a biopharmaceutical company based in the US specializing in medicines for immunology, oncology, and genetic diseases, initiated a collaboration with Mammoth Biosciences, a US-based biotech company established by Jennifer Doudna, known for its expertise in CRISPR-based gene editing. Through this alliance, Regeneron intends to utilize Mammoth’s ultra-small CRISPR platforms in conjunction with Regeneron’s delivery innovations to expedite the creation of in vivo gene editing treatments for tissues outside the liver, consequently broadening Regeneron’s therapeutic offerings and technological capabilities. Mammoth Biosciences, a US-based entity, supplies CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for both therapeutic and diagnostic uses.

Who Are The Prominent Global Companies Shaping The Genome Editing/Genome Engineering Market Landscape?

Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Which Region Is Projected To Lead The Genome Editing/Genome Engineering Market During The Forecast Period?

North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genome Editing/Genome Engineering Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8010&type=smp

Browse Through More Reports Similar to the Global Genome Editing/Genome Engineering Market 2026, By The Business Research Company

Gene Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Crispr Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795